Skip to main content
Livermore
Livermore
ZHEN

Akero Therapeutics, Inc.

AKRODelisted Dec 9, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001744659

Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Akero Therapeutics, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of AKRO: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders156157+1
Shares48.1M56.4M+8.30M (+17.3%)
Value$1.84B$2.63B+$792.6M (+43.1%)

New holders (26)

Institutions that held Akero Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to AKRO in Q2 2023
InstitutionSharesValue% of portfolio
General Atlantic LLC1,785,714$83.4M1.31%
Pictet Asset Management SA1,144,082$53.4M0.06%
Lord, Abbett & Co. LLC306,228$14.3M0.05%
OrbiMed Advisors LLC199,500$9.31M0.18%
Pier Capital, LLC147,841$6.90M0.99%
Cormorant Asset Management, LP115,000$5.37M0.31%
International Biotechnology Trust PLC78,489$3.66M1.11%
Balyasny Asset Management LLC77,533$3.62M0.01%
Tekla Capital Management LLC61,497$2.87M0.11%
State of New Jersey Common Pension Fund D53,742$2.51M0.01%
Moore Capital Management, LP46,839$2.19M0.05%
Parkman Healthcare Partners LLC35,000$1.63M0.28%
Connor, Clark & Lunn Investment Management Ltd.23,738$1.11M0.01%
Franklin Resources Inc18,245$851.9K0.00%
Campbell & CO Investment Adviser LLC17,950$838.1K0.15%
Fred Alger Management, LLC13,783$643.5K0.00%
Trexquant Investment LP10,073$470.3K0.01%
Lazard Asset Management LLC6,349$296.0K0.00%
Nan Fung Group Holdings Ltd4,425$206.6K0.13%
Global Retirement Partners, LLC4,379$204.5K0.01%
Martingale Asset Management L P4,314$201.4K0.00%
Knott David M Jr2,000$94.0K0.04%
Belvedere Trading LLC1,758$82.1K0.03%
STRS Ohio400$18.0K0.00%
Impact Partnership Wealth, LLC28$1.31K0.00%
Gradient Investments LLC1$470.00%

Sold out (25)

Institutions that held Akero Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of AKRO in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Renaissance Technologies LLC168,900$6.46M
Tri Locum Partners LP88,524$3.39M
Voloridge Investment Management, LLC84,907$3.25M
Ikarian Capital, LLC50,000$1.91M
Tudor Investment Corp Et Al36,885$1.41M
Twinbeech Capital LP20,595$788.0K
Squarepoint Ops LLC20,091$768.7K
Cubist Systematic Strategies, LLC19,778$756.7K
HighVista Strategies LLC18,629$712.7K
Two Sigma Advisers, LP18,200$696.3K
HRT Financial LP16,489$630.0K
Ergoteles LLC15,822$605.4K
Capital Fund Management S.A.15,231$582.7K
Boothbay Fund Management, LLC10,035$383.9K
Fox Run Management, L.L.C.7,924$303.2K
XTX Topco Ltd7,470$285.8K
Wolverine Trading, LLC6,488$245.0K
Boulder Hill Capital Management LP5,900$225.7K
Verition Fund Management LLC5,360$205.1K
Jefferies Financial Group Inc.2,226$85.2K
Crewe Advisors LLC242$9.26K
Point72 Middle East FZE124$4.74K
TCI Wealth Advisors, Inc.105$4.02K
Ellevest, Inc.100$3.83K
Red Tortoise LLC30$1.15K